U.S. markets close in 1 hour 1 minute
  • S&P 500

    3,606.96
    -33.51 (-0.92%)
     
  • Dow 30

    28,876.92
    -348.69 (-1.19%)
     
  • Nasdaq

    10,657.96
    -79.55 (-0.74%)
     
  • Russell 2000

    1,679.23
    +4.29 (+0.26%)
     
  • Crude Oil

    79.56
    -1.67 (-2.06%)
     
  • Gold

    1,670.80
    +2.20 (+0.13%)
     
  • Silver

    19.06
    +0.35 (+1.86%)
     
  • EUR/USD

    0.9813
    -0.0007 (-0.07%)
     
  • 10-Yr Bond

    3.7540
    +0.0070 (+0.19%)
     
  • GBP/USD

    1.1180
    +0.0056 (+0.51%)
     
  • USD/JPY

    144.7670
    +0.3240 (+0.22%)
     
  • BTC-USD

    19,678.50
    +375.98 (+1.95%)
     
  • CMC Crypto 200

    449.21
    +5.78 (+1.30%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    -484.84 (-1.83%)
     

56 Biggest Movers From Yesterday

·3 min read

Check out these big penny stock gainers and losers
Losers

  • Vera Therapeutics, Inc. (NASDAQ: VERA) shares tumbled 26.5% to settle at $22.48.

  • MacroGenics, Inc. (NASDAQ: MGNX) fell 23.8% to close at $20.99 as the company disclosed results from Cohort A Part 1 of the Phase 2/3 MAHOGANY clinical trial of margetuximab.

  • Silverback Therapeutics, Inc. (NASDAQ: SBTX) shares dipped 23.1% to close at $12.50 on Thursday. The company presented interim clinical results from a Phase 1/1b clinical study of SBT6050 as a monotherapy and in combination with Merck & Co's Keytruda in patients with advanced or metastatic HER2-expressing or amplified solid tumors.

  • Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) declined 21.4% to close at $12.34 after the company announced topline results of its Phase 2b COMET-1 study evaluating AR-15512 (TRPM8 Agonist) ophthalmic solution for dry eye disease. The company said that the study failed to achieve statistical significance at pre-determined primary endpoints at Day 28.

  • Tyra Biosciences, Inc. (NASDAQ: TYRA) fell 20% to settle at $20.81. The company recently priced its IPO at $17 per share.

  • iHuman Inc. (NYSE: IH) dropped 17.5% to close at $5.16.

  • PROCEPT BioRobotics Corporation (NASDAQ: PRCT) fell 14.4% to close at $35.91. The company recently priced its IPO at $25 a share.

  • Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) dipped 14.3% to close at $12.15. Ayala Pharmaceuticals highlighted presentation of preliminary clinical data from ongoing Phase 2 ACCURACY Trial and announced pre-clinical proof of concept data for enhanced activity of AL101 in combination with approved cancer therapies in adenoid cystic carcinoma.

  • Marine Products Corporation (NYSE: MPX) declined 14% to close at $12.55.

  • G Medical Innovations Holdings Ltd (NASDAQ: GMVD) fell 12.8% to settle at $2.60 after the company reported financial results for the six months ended June 30, 2021.

  • Imago BioSciences, Inc. (NASDAQ: IMGO) dropped 12.5% to close at $23.94.

  • Berkeley Lights, Inc. (NASDAQ: BLI) dipped 11.6% to close at $23.53. Berkeley Lights dropped around 19% on Wednesday in reaction to a bearish short report on the stock from Scorpion Capital.

  • Coeur Mining, Inc. (NYSE: CDE) fell 11.3% to close at $6.29 as gold prices dropped amid a rise in the US dollar.

  • Seer, Inc. (NASDAQ: SEER) dropped 10.9% to close at $36.13.

  • Hecla Mining Company (NYSE: HL) fell 7.8% to close at $5.68 as gold prices dropped amid a rise in the US dollar.

  • Mechel PAO (NYSE: MTL) fell 7% to close at $4.23 after jumping 10% on Wednesday.

  • AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI) shares fell 6.2% to close at $2.41. The company recently announced definitive agreement to acquire food production & processing IP from Manna Nutritional Group.

  • Pasithea Therapeutics Corp. (NASDAQ: KTTA) fell 5.9% to close at $3.35. Pasithea Therapeutics shares declined around 29% on Wednesday as the company priced its IPO at $5 per unit.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.